AVID BIOSERVICES, INC. (CDMO) Financial Statements
AVID BIOSERVICES, INC. (CDMO) files with the U.S. Securities and Exchange Commission under CIK 0000704562. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2024
- Revenue
- $139.91 million
- Net Income
- -$140.75 million
- Total Assets
- $336.56 million
- Net Cash from Operations
- $10.95 million
Fiscal year ended Apr 30, 2024. Latest periodic SEC filing: Dec 10, 2024. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for CDMO in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History